Approved Drugs for Psychiatry/Psychology

Drugs Approved in 2008

• Aplenzin (bupropion hydrobromide); For the treatment of major depressive disorder; Biovail Labs; Approved April 2008
• Stavzor (valproic acid delayed release); For the treatment of bipolar manic disorder, seizures and migraine headaches; Banner Pharmacaps; Approved July 2008
• Stavzor (valproic acid delayed release); For the treatment of bipolar manic disorder, seizures and migraine headaches; Banner Pharmacaps; Approved July 2008

Drugs Approved in 2007

• Vyvanse (Lisdexamfetamine Dimesylate); For the treatment of Attention-Deficit/Hyperactivity Disorder; New River; Approved February 2007

Drugs Approved in 2006

• Chantix (varenicline); For the treatment of nicotine addiction; Pfizer; Approved May 2006
• Invega (paliperidone); For the treatment of schizophrenia; Janssen LP; Approved December 2006

Drugs Approved in 2005

Drugs Approved in 2004

• Cymbalta (duloxetine); For the treatment of major depressive disorder; Eli Lilly; Approved August 2004

Drugs Approved in 2003

Drugs Approved in 2002

• Abilify (aripiprazole); Oral drug for the treatment of schizophrenia; Bristol-Myers Squibb, Otsuka America Pharmaceutical; Approved November 2002
• Geodon (ziprasidone mesylate); To control agitated behavior and psychotic symptoms in schizophrenia patients; Pfizer; Approved June 2002
• Lexapro (escitalopram oxalate); An orally administered selective serotonin reuptake inhibitor useful for the treatment for major depressive disorder; Forest Laboratories; Approved August 2002
• Paxil CR; Oral tablet for the treatment of depression and panic disorder; GlaxoSmithKline; Approved February 2002
• Ritalin LA (methylphenidate HCl); Oral capsules for the treatment Attention-Deficit/Hyperactivity Disorder (ADHD); Novartis; Approved June 2002
• Strattera (atomoxetine HCl); For the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children, adolescents and adults.; Eli Lilly; December 2002
• Subutex/Suboxone (buprenorphine/naloxone); Oral tablets for the treatment of opiate dependence; Reckitt Benckiser; Approved October 2002
• Zoloft (sertraline HCl); Oral tablets for the treatment of premenstrual dysphoric mood disorder (PMDD); Pfizer; Approved May 2002

Drugs Approved in 2001

• Adderall XR; Once-daily medication for the treatment of attention deficit/hyperactivity disorder (ADHD); Shire Pharmaceuticals; Approved October 2001
• Focalin (dexmethylphenidate HCl); For the treatment of attention deficit hyperactivity disorder (ADHD); Celgene; Approved November 2001
• Metadate CD; Oral capsules for the treatment of attention deficit hyperactivity disorder; Celltech Pharmaceuticals; Approved April 2001
• Prozac Weekly (fluoxetine HCl); For the treatment of depression; Eli Lilly; Approved February 2001
• Remeron SolTab (mirtazapine); Orally disintegrating tablet for the treatment of depression; Organon; Approved January 2001
• Ziprasidone (ziprasidone hydrochloride); Oral capsule for the treatment of schizophrenia; Pfizer; Approved February 2001

Drugs Approved in 2000

• Concerta; For the treatment of Attention Deficit Hyperactivity Disorder; Alza; Approved August 2000

Drugs Approved in 1999

• Effexor; Treatment for generalized anxiety disorder; Wyeth-Ayerst Laboratories; Approved March 1999
• Paxil CR Tablets; Treatment for depression; SmithKline Beecham; Approved March 1999
• Sonata; Treatment fo insomnia; American Home Products; Approved August 1999

Drugs Approved in 1998

• Celexa; Treatment for depression; Forest Laboratories; Approved July 1998
• Clomipramine hydrochloride; Generic equivalent of Anafranil; Mylan Laboratories; Approved April 1998
• Cylert; Treatment for Attention Deficit Disorder; Abbott Laboratories; Approved October 1998
• Marplan Tablets; Treatment of Depression; Roche; Approved August 1998
• Naltrexone Hydrochloride Tablets; Generic equivalent of Revia; Barr Laboratories; Approved May 1998
• Prochlorperazine; Generic equivalent of SmithKline Beecham's Compazine; IVAX; Approved January 1998

Drugs Approved in 1997

• Effexor (R) XR (venlafaxin HCI); Treatment of depression; Wyeth-Ayerst Laboratories; Approved October 1997
• Generic Transdermal Nicotine Patch; Generic equivalent of Habitrol; Sano; Approved October 1997
• LUVOX (fluvoxamine maleate); Treatment for obsessive compulsive disorder (OCD) in children and adolescents; Solvay Pharmaceuticals, Pharmacia & Upjohn; Approved April 1997
• Seroquel (R) (quetiapine fumarate) Tablets; Treatment for schizophrenia; Zeneca Pharmaceuticals; Approved September 1997
• Trazadone 150mg; Generic equivalent of Desyrel 7; Teva Pharmaceutical; Approved May 1997
• Zoloft; Treatment of panic disorder in children ages 6-17; Pfizer; Approved October 1997
• Zoloft; Treatment for panic disorder; Pfizer; Approved July 1997
• Zyban Sustained-Release Tablets; Treatment for smoking cessation; GlaxoWellcome; Approved May 1997

Drugs Approved in 1996

• Adderall (mixed salts of a single-entity amphetamine); Treatment for attention-deficit/hyperactivity disorder; Richwood Pharmaceutical; Supplemental NDA Approved February 1996
• ARICEPT (donepezil hydrochloride); Treatment for Alzheimer's Disease; Eisai; Approved December 1996
• Depakote (divalproex sodium); Treatment for migraine headaches; Abbott Laboratories; Approved March 1996
• Lithobid (Lithium Carbonate); Treatment for manic depression; Solvay Pharmaceuticals; Approved January 1996
• NicoDerm CQ; Treatment for smoking cessation; SmithKline Beecham, Hoechst Marion Roussel, Alza; Approved August 1996
• Nicorette (nicotine polacrilex); Over-the-counter aid in smoking cessation; SmithKline Beecham; Approved February 1996
• Nicotrol (Nicotine Transdermal System); Treatment for smoking cessation; McNeil Consumer Products; Approved July 1996
• Nicotrol NS; Treatment for nicotine addiction; Pharmacia & Upjohn; Approved March 1996
• Paxil (paroxetine hydrochloride); Treatment for panic disorder; SmithKline Beecham; Approved May 1996
• Redux (dexfenfluramine hydrochloride); Treatment for obesity; Wyeth-Ayerst Laboratories; Approved May 1996
• Remeron (Mirtazapine); Treatment for depression; Organon; Approved June 1996
• Risperdal Oral Formulation; Treatment for schizophrenia; Janssen Pharmaceutica; Approved July 1996
• Zyprexa; Treatment of the symptoms of psychotic disorders; Eli Lilly; Approved September 1996

Drugs Approved in 1995